CELZ RSI Chart
Last 7 days
-5.5%
Last 30 days
-23.8%
Last 90 days
0.2%
Trailing 12 Months
-33.8%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 0 | 0 | 0 | 0 |
2023 | 0 | 0 | 0 | 0 |
2022 | 102.8K | 92.8K | 120.8K | 103.6K |
2021 | 0 | 132.4K | 114.5K | 105.3K |
2020 | 165.3K | 165.0K | 164.8K | 164.5K |
2019 | 165.6K | 222.4K | 227.5K | 165.5K |
2018 | 34.7K | 64.6K | 94.5K | 124.4K |
2017 | 0 | 0 | 0 | 4.8K |
2016 | 15.4K | 0 | 0 | 0 |
2015 | 17.6K | 17.8K | 18.0K | 19.8K |
2014 | 19.0K | 18.6K | 18.6K | 18.7K |
2013 | 19.9K | 20.2K | 19.7K | 19.4K |
2012 | 19.3K | 19.7K | 20.3K | 19.2K |
2011 | 15.1K | 16.1K | 17.0K | 18.0K |
2010 | 0 | 0 | 0 | 14.1K |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Jun 28, 2023 | warbington timothy | bought | 872 | 4.36 | 200 | president & ceo |
Jun 27, 2023 | warbington timothy | bought | 3,551 | 4.43875 | 800 | president & ceo |
Nov 22, 2022 | warbington timothy | bought | 3,897 | 0.389742 | 10,000 | president & ceo |
Nov 21, 2022 | warbington timothy | bought | 5,965 | 0.397667 | 15,000 | president & ceo |
Sep 27, 2022 | finger michael h. | bought | 1,000 | 0.5 | 2,000 | - |
Sep 27, 2022 | warbington timothy | bought | 10,000 | 0.5 | 20,000 | president & ceo |
Sep 22, 2022 | warbington timothy | bought | 6,480 | 0.54 | 12,000 | president & ceo |
Sep 21, 2022 | warbington timothy | bought | 18,337 | 0.611242 | 30,000 | president & ceo |
Jun 14, 2022 | finger michael h. | bought | 7,000 | 0.7 | 10,000 | - |
Jun 06, 2022 | warbington timothy | bought | 22,884 | 0.91536 | 25,000 | president & ceo |
Which funds bought or sold CELZ recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 10, 2024 | VANGUARD GROUP INC | added | 0.02 | 10,593 | 91,863 | -% |
May 10, 2024 | OSAIC HOLDINGS, INC. | unchanged | - | - | 5.00 | -% |
May 10, 2024 | WELLS FARGO & COMPANY/MN | unchanged | - | 6.00 | 57.00 | -% |
May 07, 2024 | O'Dell Group, LLC | sold off | -100 | -5.00 | - | -% |
May 01, 2024 | CONCOURSE FINANCIAL GROUP SECURITIES, INC. | sold off | - | - | - | -% |
Apr 25, 2024 | Aaron Wealth Advisors LLC | new | - | 85,444 | 85,444 | 0.01% |
Feb 13, 2024 | Tower Research Capital LLC (TRC) | reduced | -36.59 | -2,843 | 4,163 | -% |
Feb 13, 2024 | MORGAN STANLEY | unchanged | - | -6.00 | 92.00 | -% |
Feb 09, 2024 | UBS Group AG | reduced | -4.58 | -569 | 4,804 | -% |
Jan 09, 2024 | IFP Advisors, Inc | unchanged | - | -2.00 | 23.00 | -% |
Unveiling Creative Medical Technology Holdings's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Date Filed | Form Type | Document | |
---|---|---|---|
Peers (Alternatives to Creative Medical Technology Holdings)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MRNA | 47.0B | 6.8B | -7.88 | 6.87 | ||||
HILS | 22.5B | 216.3K | -2.5K | 104.0K | ||||
ALNY | 19.1B | 2.0B | -57.66 | 9.56 | ||||
BMRN | 15.5B | 2.5B | 75.52 | 6.28 | ||||
INCY | 12.0B | 3.8B | 16.12 | 3.19 | ||||
MID-CAP | ||||||||
BBIO | 5.4B | 107.9M | -9.96 | 48.09 | ||||
APLS | 5.1B | 524.1M | -12.21 | 9.72 | ||||
AXSM | 3.4B | 251.0M | -11.62 | 13.72 | ||||
ARWR | 2.7B | 240.7M | -5.82 | 12.77 | ||||
ACAD | 2.5B | 813.8M | -1.5K | 3.1 | ||||
SMALL-CAP | ||||||||
CPRX | 1.8B | 411.3M | 28.39 | 4.49 | ||||
NVAX | 627.6M | 996.6M | -1.57 | 0.63 | ||||
CRBP | 467.4M | 881.7K | -13.85 | 481.06 | ||||
INO | 261.3M | 4.9M | -1.93 | 53.69 | ||||
IBIO | 6.6M | 2.1M | -0.24 | 2.14 |
Creative Medical Technology Holdings News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Revenue | - | - | - | 89,233 | 89,913 | 70,215 | 50,517 | 38,083 | - | 15,000 | 67,754 | 10,000 | 10,000 | 17,500 | 77,000 | 27,900 | 42,100 | 49,800 | 57,500 | 61,600 | 50,800 | 57,600 |
Cost Of Revenue | -100.0% | - | 1,200 | 2,400 | - | - | 5,700 | 16,000 | - | 6,791 | 39,449 | 4,000 | 4,500 | 8,000 | 17,600 | 10,800 | 14,196 | 4,060 | 8,000 | 19,200 | 14,239 | 29,052 |
Gross Profit | -100.0% | - | 1,800 | 3,600 | - | - | 12,900 | 39,000 | - | 8,209 | 28,305 | 6,000 | 5,500 | 9,500 | 59,400 | 17,100 | 27,904 | -8,460 | 49,500 | 42,400 | 36,561 | 28,548 |
Operating Expenses | -36.7% | 1,123,147 | 1,773,639 | 1,546,785 | 1,192,038 | 1,113,070 | 6,290,837 | 1,059,422 | 1,791,144 | 1,163,078 | 1,501,032 | 839,436 | 521,342 | 332,564 | 301,871 | 231,364 | 362,940 | 322,129 | 322,922 | 317,858 | 287,260 | 348,892 |
S&GA Expenses | -52.0% | 671,484 | 1,398,710 | 531,042 | 859,537 | 771,020 | 899,597 | 805,461 | 1,108,428 | 1,130,057 | 1,428,011 | 757,235 | 498,321 | 315,793 | 285,100 | 214,886 | 346,168 | 311,037 | 317,636 | 312,572 | 281,974 | 257,269 |
R&D Expenses | 20.9% | 422,392 | 349,408 | 992,722 | 309,480 | 319,029 | - | 230,940 | 659,695 | 10,000 | 50,000 | 59,180 | - | - | - | - | - | - | - | - | - | 86,337 |
EBITDA Margin | 0.2% | -50.93 | -51.03 | -94.82 | -90.27 | -96.92 | -97.92 | -44.70 | -53.44 | -56.80 | 223 | -116 | -91.51 | - | - | - | - | - | - | - | - | - |
Interest Expenses | - | - | - | - | -50.00 | 50.00 | - | - | - | - | 2,402,746 | 1,305,273 | 234,338 | 319,354 | 289,210 | 297,803 | 323,223 | 407,544 | 529,188 | 504,254 | 454,542 | 380,086 |
Income Taxes | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Earnings Before Taxes | 38.0% | -1,041,544 | -1,678,574 | -1,453,952 | -1,102,125 | -1,051,923 | -6,215,692 | -982,339 | -1,791,144 | -1,154,869 | -3,875,473 | -1,843,596 | -2,905,182 | -38,619,998 | 394,851 | -1,842,563 | 3,742,480 | -5,191,950 | -2,406,124 | -88,233 | -797,366 | 1,934,351 |
EBT Margin | 0.2% | -50.93 | -51.03 | -94.82 | -90.27 | -96.92 | -97.92 | -64.58 | -93.42 | -95.17 | 182 | -135 | -100 | - | - | - | - | - | - | - | - | - |
Net Income | 38.0% | -1,041,544 | -1,678,574 | -1,453,952 | -1,102,125 | -1,051,923 | -6,215,692 | -982,339 | -1,791,144 | -1,154,869 | -3,875,473 | -1,843,596 | -2,905,182 | -38,619,998 | 394,851 | -1,842,563 | 3,742,480 | -5,191,950 | -2,406,124 | -88,233 | -797,366 | 1,934,351 |
Net Income Margin | 0.2% | -50.93 | -51.03 | -94.82 | -90.27 | -96.92 | -97.92 | -64.58 | -93.42 | -95.17 | 182 | -135 | -100 | - | - | - | - | - | - | - | - | - |
Free Cashflow | 52.7% | -896,864 | -1,894,983 | -1,304,523 | -986,737 | -3,841,642 | -3,591,234 | -873,303 | -1,755,536 | -1,576,893 | -1,161,336 | -390,789 | -222,139 | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Assets | -10.2% | 9,620 | 10,715 | 12,514 | 14,127 | 15,229 | 19,186 | 22,468 | 23,434 | 9,734 | 11,268 | 3,132 | 732 | 872 | 718 | 425 | 443 | 469 | 531 | 330 | 358 | 578 |
Current Assets | -10.4% | 9,205 | 10,271 | 12,044 | 13,735 | 14,814 | 18,747 | 22,006 | 22,949 | 9,226 | 10,737 | 2,578 | 159 | 275 | 98.00 | 39.00 | 40.00 | 50.00 | 94.00 | 183 | 205 | 420 |
Cash Equivalents | 159.8% | 9,007 | 3,467 | 4,507 | 3,990 | 9,516 | 8,321 | 16,969 | 22,864 | 9,147 | 10,724 | 2,378 | 159 | 275 | 98.00 | 39.00 | 37.00 | 38.00 | 89.00 | 158 | 204 | 419 |
Inventory | 0% | 7.00 | 7.00 | 8.00 | 10.00 | 10.00 | 10.00 | 16.00 | 21.00 | 14.00 | 11.00 | - | - | - | - | - | 1.00 | 3.00 | - | - | - | - |
Liabilities | 5.3% | 391 | 371 | 421 | 399 | 408 | 3,322 | 2,754 | 2,186 | 1,618 | 1,050 | - | - | - | 40,521 | 3,202 | 4,648 | 3,652 | 8,602 | 3,893 | 2,995 | 4,183 |
Current Liabilities | 5.3% | 391 | 371 | 421 | 399 | 408 | 3,322 | 397 | 390 | 380 | 1,050 | 3,495 | 1,447 | 3,314 | 40,521 | 3,202 | 4,648 | 3,652 | 8,602 | 3,893 | 2,995 | 4,183 |
Shareholder's Equity | -10.8% | 9,229 | 10,344 | 12,092 | 13,729 | 14,822 | 15,865 | 22,071 | 23,044 | 9,354 | 10,218 | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings | -1.8% | -60,139 | -59,098 | -57,419 | -55,965 | -54,863 | -53,811 | -47,596 | -46,613 | -44,822 | -43,667 | -38,803 | -36,959 | -34,054 | -61,890 | -23,270 | -23,665 | -21,822 | -25,565 | -20,373 | -17,966 | -17,878 |
Additional Paid-In Capital | 0.0% | 69,721 | 69,712 | 69,703 | 69,693 | 69,672 | 69,675 | 69,653 | 69,644 | 54,170 | 53,879 | 38,434 | 34,560 | 30,001 | 22,083 | 20,015 | 19,212 | 18,552 | 17,490 | 14,699 | 14,139 | 13,263 |
Shares Outstanding | -1.2% | 1,357 | 1,374 | 1,391 | 1,431 | 1,408 | 1,408 | 1,408 | 1,396 | 652 | 634 | 245 | 232 | - | - | - | - | - | - | - | - | - |
Float | - | - | - | - | 6,633 | - | - | - | 6,194 | - | - | - | 38,245 | - | - | - | 1,139 | - | 4,632 | - | - | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Cashflow From Operations | 52.7% | -896 | -1,894 | -1,304 | -986 | -3,841 | -3,591 | -873 | -1,755 | -1,576 | -1,161 | -390 | -222 | -441 | 57.00 | -174 | -122 | -195 | -252 | -358 | -329 | -273 |
Share Based Compensation | 0% | 9.00 | 9.00 | 9.00 | 9.00 | 9.00 | 9.00 | 9.00 | 9.00 | 41.00 | - | 384 | - | - | 102 | - | - | - | - | - | - | - |
Cashflow From Investing | 479.2% | 6,520 | 1,126 | 1,822 | -4,539 | 5,037 | -5,057 | -5,021 | - | - | 200 | -200 | - | - | -250 | - | - | - | - | - | - | - |
Cashflow From Financing | 69.4% | -82.80 | -270 | - | - | - | - | 12* | 15,472 | - | 9,307 | 2,810 | 106 | 619 | 252 | 176 | 121 | 145 | 183 | 312 | 114 | 388 |
Buy Backs | 4.6% | 83.00 | 79.00 | 192 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) | 12 Months Ended | |
---|---|---|
Dec. 31, 2023 | Dec. 31, 2022 | |
CONSOLIDATED STATEMENTS OF OPERATIONS | ||
Revenues | $ 9,000 | $ 88,600 |
Cost of revenues | 3,600 | 28,491 |
Gross profit | 5,400 | 60,109 |
OPERATING EXPENSES | ||
Research and development | 1,970,639 | 6,268,854 |
Selling, general and administrative | 3,560,309 | 3,943,543 |
Amortization of patent costs | 94,584 | 92,084 |
TOTAL EXPENSES | 5,625,532 | 10,304,481 |
Operating loss | (5,620,132) | (10,244,372) |
OTHER INCOME/(EXPENSE) | ||
Interest income | 333,558 | 100,328 |
Total other income (expense) | 333,558 | 100,328 |
LOSS BEFORE PROVISION FOR INCOME TAXES | (5,286,574) | (10,144,044) |
Provision for income taxes | 0 | 0 |
NET LOSS | $ (5,286,574) | $ (10,144,044) |
NET LOSS PER SHARE - BASIC AND DILUTED | $ (3.76) | $ (9.28) |
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING - BASIC AND DILUTED | 1,407,632 | 1,093,204 |
CONSOLIDATED BALANCE SHEETS - USD ($) | Dec. 31, 2023 | Dec. 31, 2022 |
---|---|---|
CURRENT ASSETS | ||
Cash | $ 3,466,867 | $ 8,320,519 |
Investments | 6,520,191 | 10,078,617 |
Inventory | 6,594 | 10,194 |
Prepaids and other current assets | 277,246 | 338,120 |
Total Current Assets | 10,270,898 | 18,747,450 |
OTHER ASSETS | ||
Other assets | 3,281 | 3,281 |
Licenses, net of amortization | 441,011 | 435,595 |
TOTAL ASSETS | 10,715,190 | 19,186,326 |
CURRENT LIABILITIES | ||
Accounts payable | 317,280 | 3,267,538 |
Accrued expenses | 39,920 | 39,920 |
Advances from related party | 14,194 | 14,194 |
Total Current Liabilities | 371,394 | 3,321,652 |
TOTAL LIABILITIES | 371,394 | 3,321,652 |
STOCKHOLDERS' EQUITY | ||
Common stock, $0.001 par value, 5,000,000 and 50,000,000 shares authorized; 1,431,126 and 1,407,625 issued and 1,373,626 and 1,407,624 outstanding at December 31, 2023 and 2022, respectively | 1,431 | 1,407 |
Additional paid-in capital | 69,711,749 | 69,675,125 |
Accumulated deficit | (59,098,432) | (53,811,858) |
Treasury stock, at cost, 57,500 shares as of December 31, 2023 | (270,952) | 0 |
TOTAL STOCKHOLDERS' EQUITY | 10,343,796 | 15,864,674 |
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY | $ 10,715,190 | $ 19,186,326 |